Authors:
VANDERMEIDE PH
VILLINGER F
ANSARI AA
GATELY MK
SCHELLEKENS H
WIJDENES J
Citation: Ph. Vandermeide et al., INTERLEUKIN-12 STRONGLY POTENTIATES THE IMMUNOGENICITY OF THE CANDIDATE VACCINE MOLECULE HIV-1GP120 IN RHESUS-MONKEYS, European cytokine network, 9(3), 1998, pp. 231-231
Authors:
WENDLING D
RACADOT E
WIJDENES J
SIBILIA J
FLIPO RM
CANTAGREL A
MIOSSEC P
ESCHARD JP
MACRO M
BERTIN P
LIOTE F
DEBIAIS F
JUVIN R
LEGOFF P
MASSON C
Citation: D. Wendling et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER TRIAL OF MURINE ANTI-CD4 MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS, Journal of rheumatology, 25(8), 1998, pp. 1457-1461
Authors:
THIEL S
BEHRMANN I
DITTRICH E
MUYS L
TAVERNIER J
WIJDENES J
HEINRICH PC
GRAEVE L
Citation: S. Thiel et al., INTERNALIZATION OF THE INTERLEUKIN-6 SIGNAL TRANSDUCER GP130 DOES NOTREQUIRE ACTIVATION OF THE JAK STAT PATHWAY/, Biochemical journal, 330, 1998, pp. 47-54
Authors:
OVIGNE JM
VERMOTDESROCHES C
LECRON JC
PORTIER M
LUPKER J
PECCEU F
WIJDENES J
Citation: Jm. Ovigne et al., AN ANTAGONISTIC MONOCLONAL-ANTIBODY (B-N6) SPECIFIC FOR THE HUMAN NEUROTENSIN RECEPTOR-1, Neuropeptides, 32(3), 1998, pp. 247-256
Authors:
AZIMZADEH A
ROMAIN N
VERMOTDESROCHES C
CHENARD MP
MEYER C
WIJDENES J
HERVE P
CINQUALBRE J
WOLF P
Citation: A. Azimzadeh et al., REACTIVITY OF ANTI-HUMAN ADHESION MOLECULES AND VON-WILLEBRAND-FACTORMONOCLONAL-ANTIBODIES WITH PIG ANTIGENS, Transplantation proceedings, 30(6), 1998, pp. 2849-2850
Authors:
MULLERNEWEN G
KUSTER A
HEMMANN U
KEUL R
HORSTEN U
MARTENS A
GRAEVE L
WIJDENES J
HEINRICH PC
Citation: G. Mullernewen et al., SOLUBLE IL-6 RECEPTOR POTENTIATES THE ANTAGONISTIC ACTIVITY OF SOLUBLE GP130 ON IL-6 RESPONSES, The Journal of immunology (1950), 161(11), 1998, pp. 6347-6355
Authors:
HAMMACHER A
RICHARDSON RT
LAYTON JE
SMITH DK
ANGUS LJL
HILTON DJ
NICOLA NA
WIJDENES J
SIMPSON RJ
Citation: A. Hammacher et al., THE IMMUNOGLOBULIN-LIKE MODULE OF GP130 IS REQUIRED FOR SIGNALING BY INTERLEUKIN-6, BUT NOT BY LEUKEMIA INHIBITORY FACTOR, The Journal of biological chemistry, 273(35), 1998, pp. 22701-22707
Citation: Jm. Dore et al., IDENTIFICATION AND LOCATION ON SYNDECAN-1 CORE PROTEIN OF THE EPITOPES OF B-B2 AND B-B4 MONOCLONAL-ANTIBODIES, FEBS letters, 426(1), 1998, pp. 67-70
Authors:
JOURDAN M
FERLIN M
LEGOUFFE E
HORVATHOVA M
LIAUTARD J
ROSSI JF
WIJDENES J
BROCHIER J
KLEIN B
Citation: M. Jourdan et al., THE MYELOMA CELL ANTIGEN SYNDECAN-1 IS LOST BY APOPTOTIC MYELOMA CELLS, British Journal of Haematology, 100(4), 1998, pp. 637-646
Authors:
LLORENTE L
GARCIAPADILLA C
RICHAUDPATIN Y
WIJDENES J
CARDIEL M
ALCOCERVARELA J
ALARCONSEGOVIA D
GALANAUD P
EMILIE D
Citation: L. Llorente et al., TREATMENT OF SYSTEMIC LUPUS-ERYTHEMATOSUS WITH AN ANTI-INTERLEUKIN-10MONOCLONAL-ANTIBODY, Arthritis and rheumatism, 41(9), 1998, pp. 462-462
Authors:
MINTY A
ASSELIN S
BENSUSSAN A
SHIRE D
VITA N
VYAKARNAM A
WIJDENES J
FERRARA P
CAPUT D
Citation: A. Minty et al., THE RELATED CYTOKINES INTERLEUKIN-13 AND INTERLEUKIN-4 ARE DISTINGUISHED BY DIFFERENTIAL PRODUCTION AND DIFFERENTIAL-EFFECTS ON T-LYMPHOCYTES, European cytokine network, 8(2), 1997, pp. 203-213
Authors:
MONTEROJULIAN FA
BRAILLY H
SAUTES C
JOYEUX I
DORVAL T
MOSSERI V
YASUKAWA K
WIJDENES J
ADLER A
GORIN I
FRIDMAN WH
TARTOUR E
Citation: Fa. Monterojulian et al., CHARACTERIZATION OF SOLUBLE GP130 RELEASED BY MELANOMA CELL-LINES - APOLYVALENT ANTAGONIST OF CYTOKINES FROM THE INTERLEUKIN-6 FAMILY, Clinical cancer research, 3(8), 1997, pp. 1443-1451
Authors:
CAVAZZANACALVO M
JABADO N
BORDIGONI P
MICHEL G
HADDAD E
MECHINAUD F
LANDMANPARKER J
LEBLANC T
PLOUVIER E
BARUCHEL A
STEPHAN JL
SOUILLET G
VILMER E
WIJDENES J
LEDEIST F
FISCHER A
Citation: M. Cavazzanacalvo et al., IN-VIVO INFUSION OF ANTI-LFA-1 AND ANTI-CD2 ANTIBODIES PREVENTS GRAFTFAILURE AFTER HLA PARTIALLY INCOMPATIBLE BONE-MARROW TRANSPLANTATION IN CHILDREN WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia & lymphoma, 28(1-2), 1997, pp. 103-112
Authors:
GALEA P
VERMOTDESROCHES C
LECONTEL C
WIJDENES J
CHERMANN JC
Citation: P. Galea et al., CIRCULATING CELL-ADHESION MOLECULES IN HIV-1-INFECTED PATIENTS AS INDICATOR MARKERS FOR AIDS PROGRESSION, Research in immunology, 148(2), 1997, pp. 109-117
Authors:
ROBINET E
STAMM C
NICOLAS JF
FAURE M
MERCATELLO A
CORONEL B
WIJDENES J
BIENVENU J
REVILLARD JP
CLAUDY A
Citation: E. Robinet et al., CD4 MONOCLONAL-ANTIBODY ADMINISTRATION IN ATOPIC-DERMATITIS, Journal of the American Academy of Dermatology, 36(4), 1997, pp. 582-588
Authors:
SUN RX
LU ZY
WIJDENES J
BROCHIER J
HERTOG C
ROSSI JF
KLEIN B
Citation: Rx. Sun et al., LARGE-SCALE AND CLINICAL GRADE PURIFICATION OF SYNDECAN-1 PLUS MALIGNANT PLASMA-CELLS, Journal of immunological methods, 205(1), 1997, pp. 73-79
Authors:
HORSTEN U
MULLERNEWEN G
GERHARTZ C
WOLLMER A
WIJDENES J
HEINRICH PC
GROTZINGER J
Citation: U. Horsten et al., MOLECULAR MODELING-GUIDED MUTAGENESIS OF THE EXTRACELLULAR PART OF GP130 LEADS TO THE IDENTIFICATION OF CONTACT SITES IN THE INTERLEUKIN-6 (IL-6)CENTER-DOT-IL-6 RECEPTOR-CENTER-DOT-GP130 COMPLEX, The Journal of biological chemistry, 272(38), 1997, pp. 23748-23757
Authors:
BLAY JY
ROSSI JF
WIJDENES J
MENETRIERCAUX C
SCHEMANN S
NEGRIER S
PHILIP T
FAVROT M
Citation: Jy. Blay et al., ROLE OF INTERLEUKIN-6 IN THE PARANEOPLASTIC INFLAMMATORY SYNDROME-ASSOCIATED WITH RENAL-CELL CARCINOMA, International journal of cancer, 72(3), 1997, pp. 424-430
Authors:
LEBEAU B
JULIAN FAM
WIJDENES J
MULLERNEWEN G
DAHMEN H
CHEREL M
HEINRICH PC
BRAILLY H
HALLET MM
GODARD A
MINVIELLE S
JACQUES Y
Citation: B. Lebeau et al., RECONSTITUTION OF 2 ISOFORMS OF THE HUMAN INTERLEUKIN-11 RECEPTOR ANDCOMPARISON OF THEIR FUNCTIONAL-PROPERTIES, FEBS letters, 407(2), 1997, pp. 141-147
Citation: Jm. Dore et al., EXPRESSION AND ACTIVITY OF A RECOMBINANT CHIMERIC PROTEIN COMPOSED OFPOKEWEED ANTIVIRAL PROTEIN AND OF HUMAN INTERLEUKIN-2, FEBS letters, 402(1), 1997, pp. 50-52
Authors:
DORE P
LELIEVRE E
MOREL F
BRIZARD A
FOURCIN M
CLEMENT C
INGRAND P
DANESKI L
GASCAN H
WIJDENES J
GOMBERT J
PREUDHOMME JL
LECRON JC
Citation: P. Dore et al., IL-6 AND SOLUBLE IL-6 RECEPTORS (SIL-6R AND SGP130) IN HUMAN PLEURAL EFFUSIONS - MASSIVE IL-6 PRODUCTION INDEPENDENTLY OF UNDERLYING DISEASES, Clinical and experimental immunology, 107(1), 1997, pp. 182-188
Citation: J. Wijdenes et Jm. Dore, B-B4 MONOCLONAL-ANTIBODY AND IDENTIFICATION OF HUMAN BONE-MARROW PLASMA-CELLS, British Journal of Haematology, 96(3), 1997, pp. 656-657